B

Bright Minds Biosciences Inc
CNSX:DRUG

Watchlist Manager
Bright Minds Biosciences Inc
CNSX:DRUG
Watchlist
Price: 125.15 CAD -1.4%
Market Cap: 974.9m CAD

Intrinsic Value

The intrinsic value of one DRUG stock under the Base Case scenario is hidden CAD. Compared to the current market price of 125.15 CAD, Bright Minds Biosciences Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

DRUG Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Bright Minds Biosciences Inc

Intrinsic Value History
Dive into the past to invest in the future

DRUG looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether DRUG usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about DRUG?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is DRUG valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Bright Minds Biosciences Inc.

Explain Valuation
Compare DRUG to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about DRUG?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bright Minds Biosciences Inc

Current Assets 84.3m
Cash & Short-Term Investments 82.9m
Receivables 413.1k
Other Current Assets 988k
Non-Current Assets 111.9k
PP&E 112k
Other Non-Current Assets -100
Current Liabilities 2.3m
Accounts Payable 1.7m
Accrued Liabilities 540.6k
Other Current Liabilities 84.5k
Non-Current Liabilities 41.2k
Long-Term Debt 41.3k
Other Non-Current Liabilities -100
Efficiency

Free Cash Flow Analysis
Bright Minds Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Bright Minds Biosciences Inc

Revenue
0 CAD
Operating Expenses
-13.9m CAD
Operating Income
-13.9m CAD
Other Expenses
1.7m CAD
Net Income
-12.2m CAD
Fundamental Scores

DRUG Profitability Score
Profitability Due Diligence

Bright Minds Biosciences Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
ROE is Increasing
Low 3Y Average Gross Margin
hidden
Profitability
Score

Bright Minds Biosciences Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

DRUG Solvency Score
Solvency Due Diligence

Bright Minds Biosciences Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

Bright Minds Biosciences Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DRUG Price Targets Summary
Bright Minds Biosciences Inc

There are no price targets for DRUG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Bright Minds Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DRUG is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

DRUG News

What is the Intrinsic Value of one DRUG stock?

The intrinsic value of one DRUG stock under the Base Case scenario is hidden CAD.

Is DRUG stock undervalued or overvalued?

Compared to the current market price of 125.15 CAD, Bright Minds Biosciences Inc is hidden .

Back to Top